News

A study shows that most side effects following vaccination against COVID-19 with mRNA vaccines in the USA were mild and decreased substantially after one day.

A medium-chain fatty acid found in energy drinks might one day help protect against heart attack injuries.

Research shows that a variant of the HLA-DPB1 gene is associated with a poor response to immunotherapy treatment for allergies.

Aging is associated with increased oxidative stress, glutathione deficiency and mitochondrial dysfunction. Supplementation with a combination of glycine and N-acetylcysteine can increase lifespan and reduce the hallmarks of aging in mice.

By combining polymerase and exonuclease inhibitor drugs, a team has been able to reduce SARS-CoV-2 replication 10 times further than polymerase inhibitors alone.

Recent molecular findings offer new details on how Nipah and Hendra viruses attack cells, and the immune responses that try to counter this onslaught. The results point toward multi-pronged tactics to prevent and treat these deadly illnesses.

People living in densely populated slums or favelas with limited access to healthcare have been disproportionately affected by COVID-19, but a new study has shown that the Oxford-AstraZeneca vaccine is effective in these populations.

Chemists and biologists have developed a tiny device that can locate tumor cells and force them to reveal themselves to patrolling immune cells.

The effectiveness of mRNA vaccines is reduced against all three subvariants of the Omicron variant of SARS-CoV-2 and only one authorized treatment is able to combat all of the subvariants.

Lactobacillus iners, a cause of bacterial vaginosis, has been found to have unique nutritional requirements that distinguish it from Lactobacillus crispatus, a species important to good vaginal microbiome health, opening up therapeutic opportunities.